This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Beclometasone (beclomethasone) dipropionate

Authoring team

Beclometasone (beclomethasone *) dipropionate

Inhaled preparations

  • uses include:
    • asthma prophylaxis - particularly when the condition is not fully controlled by a bronchodilator or chromoglycate
    • allergic and vasomotor rhinitis

Topical preparations

  • uses include:
    • severe eczema, psoriasis and non-responsive inflammatory skin conditions

The summary of product characteristics should be consulted before prescribing this drug.

* Beclometasone became the British Approved Name for beclomethasone in 2004

CFC containing beclamethasone pressurised metered dose inhalers (pMDI) are being phased out and it is important to switch to the newer CFC free products when possible.

  • CFC free beclamethasone inhalers are not equivalent in dose and clinicians should prescribe them in their brand names to avoid dosing errors.

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.